Last update 01 Nov 2024

Endotis Pharma SA

Private Company|
France

Overview

Basic Info

Introduction
Endotis Pharma SA is a privately-owned corporation with its main office located in Loos, France. The company specializes in the discovery and development of small glycodrugs, which are used in the treatment of thrombosis and oncology.

Related

6
Drugs associated with Endotis Pharma SA
EP-217609
Target
factor Xa x thrombin
Mechanism
factor Xa inhibitors [+1]
Active Org.-
Originator Org.
Merck & Co., Inc.Merck & Co., Inc.
Active Indication-
Inactive Indication
Thrombosis
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
EP-42675
Target
F10 x thrombin
Mechanism
F10 inhibitors [+1]
Active Org.-
Originator Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.
Active Indication-
Inactive Indication
Thrombosis
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
EP-37
Target
factor Xa
Mechanism
factor Xa inhibitors
Active Org.-
Originator Org.
Endotis Pharma SA
Active Indication-
Inactive Indication
Stroke
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Endotis Pharma SA
Login to view more data
0 Patents (Medical) associated with Endotis Pharma SA
Login to view more data
100 Deals associated with Endotis Pharma SA
Login to view more data
100 Translational Medicine associated with Endotis Pharma SA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
6
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
EP-42675
 ( F10 x thrombin )		Thrombosis
More
Discontinued
EP-217609
 ( factor Xa x thrombin )		Thrombosis
More
Discontinued
EP-37
 ( factor Xa )		Stroke
More
Pending
EP-37161
 ( HPSE x factor Xa )		Thrombosis
More
Pending
EP-80031
Anemia, Aplastic
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free